Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia". |
Therapeutic use
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
GnVHGsC5t493GZY2
